In vitro dissolution and bioavailability study of furosemide nanosuspension prepared using design of experiment (DoE)

Abstract

BackgroundNanotechnology can offer the advantages of increasing solubility and bioavailability of delivering drugs like Furosemide. The aim of the current study is to investigate the in vitro and in vivo performance of furosemide nanosuspensions.MethodsFurosemide nanosuspensions were prepared by antisolvent precipitation method using full factorial experimental design. Four factors were employed namely; Stirring time, Injection rate, antisolvent: solvent ratio & stabilizer: drug ratio (at two levels = high & low). The in vitro dissolution experiments were conducted to compare the representative formulation with raw drug powder. The bioavailability of nanosuspension was, also, evaluated in mice as an animal model.ResultsSolid state characterization (PXRD, DSC and FESEM) did show physical changes during preparation and optimization of the furosemide nanosuspensions. Individual material attributes showed more significant impact on the average particle size of the nanocrystals compared to process parameters. Two-way interactions between material attributes and process parameters significantly affected nanosuspension particle size distribution. Dissolution rate of furosemide nanosuspemsion was significantly higher than that observed for raw furosemide powder. The in vivo pharmacokinetics parameters of nanosuspension in comparison to pure drug showed significant increase in Cmax and AUC(0-t), about 233% and 266%, respectively. The oral bioavailability of furosemide from nanosuspension was about 2.3 fold higher as compared with the bioavailability from pure drug.ConclusionsFurosemide nanosuspensions prepared using antisolvent precipitation method enhanced the dissolution rate and oral bioavailability compared to raw furosemide powder.

Microfluidics for pharmaceutical nanoparticle fabrication: The truth and the myth

“…Multitudinous methods/tools with different mixing efficiencies have been assessed to be used to perform the mixing step. These include simple stirring using magnetic stirrers (Freag et al, 2013;Shariare et al, 2019) , static mixers (Dong et al, 2010) (in which solvent and antisolvent fluids are pumped at high rates (litres per min) through a small nozzles to hit mixing elements (such as blades) to induce turbulent mixing), and the recently introduced techniques that uses microfluidics including micromixer chips, and high energy input jet stream mixers (microfluidizers) (Salazar et al, 2014). Recently, the use of microfluidic systems of different channel and mixing junction geometries has been introduced to provide a controlled, tuneable and continuous scalable mean for efficient fluid mixing and nanoparticles production.…”

In vitro dissolution considerations associated with nano drug delivery systems

“…Indeed, furosemide has low solubility in gastric environment, but it exhibits site specific absorption in the stomach and upper intestine. Hence improving the solubility in gastric fluid becomes crucial for improving the overall bioavailability (Shariare et al, 2019). Weng et al successfully evaluated in vitro drug release of three poorly water-soluble drugs from polymeric NPs.…”

Stable Fatty Acid Solvates of Dasatinib, a Tyrosine Kinase Inhibitor: Prediction, Process, and Physicochemical Properties

“…Approximately 40% of the approved drugs and 90% of the drugs in the discovery pipeline are poorly soluble in water. 1 , 2 Drug substances are classified under Biopharmaceutics Classification System (BCS) classes I to IV based on their solubility and permeability. 3 , 4 Pharmaceutical molecules belonging to BCS Classes I and III are ideal over those of classes II and IV in terms of their better biopharmaceutical properties.…”